These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
204 related items for PubMed ID: 8918184
21. Rubella in pregnancy in Israel: 15 years of follow-up and remaining problems. Fogel A, Barnea BS, Aboudy Y, Mendelson E. Isr J Med Sci; 1996 May; 32(5):300-5. PubMed ID: 8641868 [Abstract] [Full Text] [Related]
22. New horizons in the control of rubella and prevention of congenital rubella syndrome in the Americas. Castillo-Solórzano C, Carrasco P, Tambini G, Reef S, Brana M, de Quadros CA. J Infect Dis; 2003 May 15; 187 Suppl 1():S146-52. PubMed ID: 12721906 [Abstract] [Full Text] [Related]
23. Progress Toward Rubella and Congenital Rubella Syndrome Control and Elimination - Worldwide, 2000-2018. Grant GB, Desai S, Dumolard L, Kretsinger K, Reef SE. MMWR Morb Mortal Wkly Rep; 2019 Oct 04; 68(39):855-859. PubMed ID: 31581161 [Abstract] [Full Text] [Related]
24. Progress toward measles and rubella elimination in Egypt. El Sayed N, Kandeel N, Barakat I, Moussa I, Alexander JP, Naouri B, Reef SE. J Infect Dis; 2011 Jul 04; 204 Suppl 1():S318-24. PubMed ID: 21666180 [Abstract] [Full Text] [Related]
25. Burden of congenital rubella syndrome after a community-wide rubella outbreak, Rio Branco, Acre, Brazil, 2000 to 2001. Lanzieri TM, Segatto TC, Siqueira MM, de Oliviera Santos EC, Jin L, Prevots DR. Pediatr Infect Dis J; 2003 Apr 04; 22(4):323-9. PubMed ID: 12690271 [Abstract] [Full Text] [Related]
26. Measles, rubella, and congenital rubella syndrome--United States and Mexico, 1997-1999. Centers for Disease Control and Prevention (CDC). MMWR Morb Mortal Wkly Rep; 2000 Nov 24; 49(46):1048-50, 1059. PubMed ID: 11105768 [Abstract] [Full Text] [Related]
27. Control and prevention of rubella: evaluation and management of suspected outbreaks, rubella in pregnant women, and surveillance for congenital rubella syndrome. MMWR Recomm Rep; 2001 Jul 13; 50(RR-12):1-23. PubMed ID: 11475328 [Abstract] [Full Text] [Related]
28. Toward rubella elimination in Poland: need for supplemental immunization activities, enhanced surveillance, and further integration with measles elimination efforts. Zimmerman L, Rogalska J, Wannemuehler KA, Haponiuk M, Kosek A, Pauch E, Plonska E, Veltze D, Czarkowski MP, Buddh N, Reef S, Stefanoff P. J Infect Dis; 2011 Jul 13; 204 Suppl 1():S389-95. PubMed ID: 21666189 [Abstract] [Full Text] [Related]
29. Epidemiology of rubella and congenital rubella syndrome in Japan before 1989. Ueda K. Vaccine; 2016 Apr 07; 34(16):1971-4. PubMed ID: 26469722 [Abstract] [Full Text] [Related]
30. Rubella control in Italy. Ciofi degli Atti M, Filia A, Revello MG, Buffolano W, Salmaso S. Euro Surveill; 2004 Apr 07; 9(4):19-21. PubMed ID: 15192262 [Abstract] [Full Text] [Related]
31. Elimination of rubella and congenital rubella syndrome--United States, 1969-2004. Centers for Disease Control and Prevention (CDC). MMWR Morb Mortal Wkly Rep; 2005 Mar 25; 54(11):279-82. PubMed ID: 15788995 [Abstract] [Full Text] [Related]
32. Rubella susceptibility in pregnant women and results of a postpartum immunization strategy in Catalonia, Spain. Vilajeliu A, García-Basteiro AL, Valencia S, Barreales S, Oliveras L, Calvente V, Goncé A, Bayas JM. Vaccine; 2015 Apr 08; 33(15):1767-72. PubMed ID: 25731790 [Abstract] [Full Text] [Related]
33. Surveillance of congenital rubella syndrome in Japan, 1978-2002: effect of revision of the immunization law. Katow S. Vaccine; 2004 Sep 28; 22(29-30):4084-91. PubMed ID: 15364460 [Abstract] [Full Text] [Related]
34. Accelerated rubella control and congenital rubella syndrome prevention strengthen measles eradication: the Costa Rican experience. Morice A, Carvajal X, León M, Machado V, Badilla X, Reef S, Lievano F, Depetris A, Castillo-Solórzano C. J Infect Dis; 2003 May 15; 187 Suppl 1():S158-63. PubMed ID: 12721908 [Abstract] [Full Text] [Related]
35. [Rubella in Poland in 2010]. Karasek E, Paradowska-Stankiewicz I. Przegl Epidemiol; 2012 May 15; 66(2):197-203. PubMed ID: 23101204 [Abstract] [Full Text] [Related]
36. Balancing evidence and uncertainty when considering rubella vaccine introduction. Lessler J, Metcalf CJ. PLoS One; 2013 May 15; 8(7):e67639. PubMed ID: 23861777 [Abstract] [Full Text] [Related]
37. Rubella immunization strategies in Canada. Furesz J, Varughese P, Acres SE, Davies JW. Rev Infect Dis; 1985 May 15; 7 Suppl 1():S191-3. PubMed ID: 4001727 [Abstract] [Full Text] [Related]
38. Modelling a Supplementary Vaccination Program of Rubella Using the 2012⁻2013 Epidemic Data in Japan. Kayano T, Lee H, Nishiura H. Int J Environ Res Public Health; 2019 Apr 25; 16(8):. PubMed ID: 31027277 [Abstract] [Full Text] [Related]
39. The opportunity and obligation to eliminate rubella from the United States. Orenstein WA, Bart KJ, Hinman AR, Preblud SR, Greaves WL, Doster SW, Stetler HC, Sirotkin B. JAMA; 1984 Apr 20; 251(15):1988-94. PubMed ID: 6700103 [Abstract] [Full Text] [Related]
40. Rubella vaccination of unknowingly pregnant women during mass campaigns for rubella and congenital rubella syndrome elimination, the Americas 2001-2008. Castillo-Solórzano C, Reef SE, Morice A, Vascones N, Chevez AE, Castalia-Soares R, Torres C, Vizzotti C, Ruiz Matus C. J Infect Dis; 2011 Sep 01; 204 Suppl 2():S713-7. PubMed ID: 21954271 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]